World's Best Scientists 2026 revealed!
Mario U. Mondelli

Mario U. Mondelli

D-Index & Metrics

Immunology

D-Index
68
Citations
17243
World Ranking
2586
National Ranking
101

Mario U. Mondelli publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Mario U. Mondelli sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 319 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Mario U. Mondelli D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Mario U. Mondelli sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Mario U. Mondelli is affiliated with the University of Pavia in Italy. Their research primarily spans the field of Medicine, with a focus on several subfields including Infectious Diseases, Epidemiology, Immunology, Molecular Biology, and Oncology.

The main topics of their work include:

  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • SARS-CoV-2 and COVID-19 Research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • COVID-19 and healthcare impacts
  • Hepatitis B Virus Studies

Recent publications authored or co-authored by Mario U. Mondelli include:

  • Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper, 2020, JHEP Reports
  • Unique immunological profile in patients with COVID-19, 2020, Cellular and Molecular Immunology
  • ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population, 2020, European Journal of Human Genetics
  • Low risk of SARS-CoV-2 transmission by fomites in real-life conditions, 2020, The Lancet Infectious Diseases
  • Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic, 2020, JHEP Reports

Frequent co-authors of Mondelli include:

  • Stefania Mantovani
  • Barbara Oliviero
  • Stefania Varchetta
  • Raffaele Bruno
  • Dalila Mele

They have published widely in certain journals, including:

  • Clinical Microbiology and Infection
  • Cancers
  • Digestive and Liver Disease
  • International Journal of Infectious Diseases
  • Journal of Hepatology

Best Publications

  • Mapping the human genetic architecture of COVID-19

    Unknown

  • Statements from the Taormina expert meeting on occult hepatitis B virus infection.

    Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia

  • Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: Evidence that T cells are directed against HBV core antigen expressed on hepatocytes

    M Mondelli;G M Vergani;A Alberti;D Vergani

  • A longitudinal analysis of hepatitis C virus replication following liver transplantation

    E. J. Gane;N. V. Naoumov;K.-P. Qian;M. U. Mondelli

  • Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

    Tobias Boettler;Philip N. Newsome;Philip N. Newsome;Mario U. Mondelli;Mojca Maticic

  • Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections.

    Barbara Oliviero;Stefania Varchetta;Enrica Paudice;Giuseppe Michelone

  • Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study

    Saving Bruno;Enrico Silini;Andrea Crosignani;Franco Borzio

  • Hepatic expansion of a virus-specific regulatory CD8+ T cell population in chronic hepatitis C virus infection

    Daniele Accapezzato;Vittorio Francavilla;Marino Paroli;Marco Casciaro

  • PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV

    Debora Franceschini;Marino Paroli;Vittorio Francavilla;Melissa Videtta

  • Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities.

    Enrico Silini;Fulvia Bono;Agostino Cividini;Antonella Cerino

  • Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis

    Sara Raimondi;Savino Bruno;Mario U. Mondelli;Patrick Maisonneuve

  • Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo

    Daniele Accapezzato;Vincenzo Visco;Vittorio Francavilla;Caroline Molette

  • ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population.

    Elisa Benetti;Rossella Tita;Ottavia Spiga;Andrea Ciolfi

  • Unique immunological profile in patients with COVID-19.

    Stefania Varchetta;Dalila Mele;Barbara Oliviero;Stefania Mantovani

  • Hepatitis C virus genotype 1b as a major risk factor associated with hepatocellular carcinoma in patients with cirrhosis: a seventeen-year prospective cohort study.

    Savino Bruno;Andrea Crosignani;Patrick Maisonneuve;Sonia Rossi

  • Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients

    Alba Muzzi;Alba Muzzi;Gioacchino Leandro;Laura Rubbia-Brandt;Richard James

  • Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study

    E Silini;R Bottelli;M Asti;S Bruno

  • Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.

    Calogero Cammà;Savino Bruno;Vito Di Marco;Danilo Di Bona

  • Towards a solution for hepatitis C virus hypervariability: Mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants

    Giulia Puntoriero;Annalisa Meola;Armin Lahm;Silvia Zucchelli

  • Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study.

    Chiara Fallerini;Sergio Daga;Stefania Mantovani;Elisa Benetti

  • Low risk of SARS-CoV-2 transmission by fomites in real-life conditions.

    Mario U Mondelli;Marta Colaneri;Elena M Seminari;Fausto Baldanti

  • Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections

    Barbara Oliviero;Antonella Cerino;Stefania Varchetta;Enrica Paudice

  • Clinical significance of hepatitis C virus genotypes

    Mario U. Mondelli;Enrico Silini

Frequent Co-Authors

Antonio Craxì
Antonio Craxì University of Palermo
Alfredo Alberti
Alfredo Alberti University of Padua
Vincenzo Barnaba
Vincenzo Barnaba Sapienza University of Rome
Carlo Ferrari
Carlo Ferrari University of Parma
Alfredo Nicosia
Alfredo Nicosia University of Naples Federico II
Massimo Colombo
Massimo Colombo Humanitas University
A. L. W. F. Eddleston
A. L. W. F. Eddleston University of Cambridge
Domenico Mavilio
Domenico Mavilio University of Milan
Fausto Baldanti
Fausto Baldanti University of Pavia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open doors to diverse career options. Many students consider nursing as a complementary pathway, especially through programs tailored for rapid progression. For example, accelerated FNP programs offer advanced training for those looking to specialize quickly as Family Nurse Practitioners.

If you’re transitioning from a non-nursing background, online RN programs for non nurses provide accessible entry points to becoming a Registered Nurse. These programs are designed to be flexible and supportive for career changers.

Additionally, some students seek the most accessible paths into nursing through the easiest accelerated nursing programs. These programs allow learners to attain a Bachelor of Science in Nursing at a faster pace with fewer barriers to entry.

For those interested in practical nursing roles, the best easiest LPN programs to get into offer straightforward pathways to become Licensed Practical Nurses. Together, these degree paths can complement immunology knowledge and expand career opportunities within health sciences.

Best Scientists Citing Mario U. Mondelli

Trending Scientists

Recently Published Articles